REFERENCES
- National Center for Health Statistics. National Health Interview Survey. U.S. Department of Health Service, Centers forDisease Control and Prevention, Hyattsville, MD, 1980–1987
- Evans R., III, etal. National Trends in the Morbidity and Mortality of Asthma inthe U.S 1987; 91(Suppl. 6)655–745
- Phelan P. D. Br. Med. J. 1994; 308: 1584–1585
- Lundergan F., Quan S., Im J. U.S. Pharmacist 1995; 53, July
- Gupta P., Hickey A. J. J. Controlled Release 1991; 17: 129–148
- Gonda I., Byron P. R. Drug Dev. Ind. Pharm. 1978; 4: 243–259
- Byron P. R. Drug Dev. Ind. Pharm. 1986; 12: 993–1015
- Bowton D. L., Goldsmith W. M., Haponik E. F. Chest 1992; 101: 305–308
- Kerem E., Levison H., Schuh S., O'Brodovich H., Reisman J., Bentur L., Canny G. J. J. Pediatr. 1993; 123: 313–317
- Idris A. H., et al. Chest 1993; 103: 665–672
- Calacone A., et al. Chest 1993; 104: 835–841
- Nakanishi A., et al. Arch. Pediatr. Adolesc. Med.
- Cutie A. J., Sciarra J. J. Pharm. Times 1989; 112: 132–143
- Rance R. W. J. Soc. Cosmet. Chem. 1974; 25: 545–561
- White M. Pharm. J. 1995; 255: 693–695
- Moren F. Int. J. Pharm. 1978; 1: 205–212
- Vidgren M. T., Paronen T. P., Karkkainen A., Karjalainen P. Int. J. Pharm. 1987; 39: 107–112
- Williams R. O., III, Repka M., Liu J. Drug Dev. Ind. Pharm. 1998; 24(8)763–770
- Williams R. O., III, Liu J., Rogers T. L. Drug Dev. Ind. Pharm. 1999; 25(12)1227–1234
- Williams R. O., III, Liu J., Koleng J. J. Pharm. Res. 1997; 14: 438–443
- U.S. Pharmacopeial Convention. United States Pharmacopeia 24/National Formulary 19. U.S. PharmacopeialConvention, Inc., Rockville, MD 1999; 1895–1912
- Dalby R. N., Byron P. R. Pharm. Res. 1988; 5(1)36–39
- Gupta P. K., Hickey A. J., Mehta R. C., Deluca P. P. Pharm. Res. 1990; 7: 82s
- Schuster J., Rubsamen R., Lloyd R., Lloyd J. Pharm. Res. 1997; 14: 354–357